Overview

Bone marrow transplant patient care Bone marrow transplant patient care

You will be cared for by a team of experts in bone marrow transplant.

Mayo Clinic's bone marrow (stem cell) transplant team is recognized internationally for its expertise in comprehensive specialty treatment for people with blood and bone marrow diseases. Mayo Clinic is one of the largest providers of bone marrow transplants in the United States. It has performed nearly 10,000 stem cell transplants at its campuses in Arizona, Florida and Minnesota.

At Mayo Clinic, bone marrow transplant experts help adults and children with leukemia and other blood, plasma and bone marrow diseases. Your doctors will talk with you about all treatment options appropriate for you, including experimental treatments, and deliver care tailored to your needs.

Mayo Clinic bone marrow transplant experts are involved in patient care and research in the Mayo Clinic Cancer Center, designated by the National Cancer Institute as a comprehensive cancer center. The Mayo Clinic Cancer Center ranks in the top tier of cancer centers in the United States for Cancer research, treatment and education. Mayo Clinic Cancer Center is also a member of the National Comprehensive Cancer Network.

Bone marrow transplant physicians collaborate Bone marrow transplant physicians collaborate

Your bone marrow transplant team collaborates to ensure you get exactly the care you need.

Mayo Clinic's experts focus on your needs, bringing to your situation the strength of their:

  • Experience. Specialists in bone marrow transplant and hematology at Mayo Clinic have extensive experience helping people with all types of diseases, including very rare ones. For example, they are leaders in the use of blood stem cell transplants to treat amyloidosis.

    Each year, more than 30,000 people with blood diseases are treated at Mayo Clinic, and more than 700 of them undergo bone marrow transplants. This experience means your doctors are prepared with the knowledge and resources to provide exactly the care you need.

  • Teamwork. At Mayo Clinic, bone marrow transplant physicians form a multidisciplinary team with experts from other areas to evaluate your condition and develop an individualized treatment plan. They work with doctors trained in blood diseases (hematologists), cancer (oncologists) and other specialties (for example, lung, heart and kidney specialists). Mayo Clinic staff efficiently coordinates care as needed between its campuses in Arizona, Florida and Minnesota.
  • Care focused on you. Mayo Clinic's bone marrow transplant specialists are focused on your needs and your family needs. Doctors, nurses, social workers and others provide whole-person care based on your goals and situation. For example, a bone marrow transplant may be conducted as a hospital-based outpatient procedure, which reduces the time you'll spend in the hospital.
  • Advanced technology. Mayo Clinic patients benefit from Mayo's nationally accredited on-site advanced cell processing laboratory to prepare cells for transplant. The Human Cellular Therapy Laboratory develops and produces safe cellular products for research and patient care. And Mayo Clinic is accredited by the National Marrow Donor Program as a specialized center for matched unrelated donor stem cell transplants.
  • Innovative research. Mayo Clinic researchers make bone marrow transplants safer and improve the lives of people who need them. Their innovative treatments harness the body's immune system, make use of new stem cell technologies and prevent complications such as graft versus host disease.

    Mayo Clinic bone marrow transplant physicians and hematologists work with other hospitals in the United States and internationally to conduct clinical trials. The close connection between clinical care and research at Mayo Clinic makes it possible for eligible patients to enroll in clinical trials, where they may receive new treatments.

    Mayo Clinic bone marrow transplant experts and hematologists are also involved in patient care and research in the Mayo Clinic Cancer Center. This center ranks in the top tier of cancer centers in the United States.

At Mayo Clinic's campus in Minnesota, children and adolescents with blood disorders receive care through the Children's Center. Children needing hospitalization receive care at Mayo Eugenio Litta Children's Hospital.

At Mayo Clinic's campus in Arizona, doctors trained in blood diseases and cancer (hematologists and oncologists) partner with Phoenix Children's Hospital to treat children who may need bone marrow transplants. Together the two hospitals oversee a single bone marrow transplant program for children.

At Mayo Clinic's campus in Florida, hematologists and oncologists partner with Nemours Children's Specialty Care and Wolfson Children's Hospital to treat children who may need bone marrow transplants.

Services

Skilled health care professionals work as a team in the Mayo Clinic Transplant Center. Transplant center team

Mayo Clinic's Bone Marrow Transplant Program provides consultations, evaluations and treatment for patients who would potentially benefit from a bone marrow transplant.

Mayo Clinic bone marrow transplant specialists work with a multidisciplinary team to determine the most appropriate treatment for you. They have expertise in many areas of bone marrow transplant, including those listed below. Not all services are available at each of Mayo Clinic's three campuses in Arizona, Florida and Minnesota. Please confirm when you call to request an appointment.

Mayo Clinic in Rochester, Minn., Mayo Clinic in Jacksonville, Fla., and Mayo Clinic in Scottsdale, Ariz., are ranked among the Best Hospitals for cancer by U.S. News & World Report.

Aug. 21, 2018
References
  1. National Marrow Donor Program. http://bethematch.org. Accessed Feb. 26, 2015.
  2. AskMayoExpert. Hematopoietic stem cell transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  3. AskMayoExpert. Graft-versus-host disease. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  4. Barbara Woodward Lips Patient Education Center. Allogeneic blood and marrow transplant (BMT). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2010.
  5. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. July 20, 2016.
  6. Lee SJ, et al. 5 year results of bmt ctn 0201: Unrelated donor bone marrow is associated with better psychological well-being and less burdensome chronic gvhd symptoms than peripheral blood. American Society of Hematology. Meeting abstract. https://ash.confex.com/ash/2015/webprogram/Paper80881.html. Accessed July 19, 2016.
  7. Adams RH (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 15, 2016.
  8. Geerdes PA (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 17, 2012.
  9. Reunited and it feels pretty good. In the Loop. July 28, 2015. http://intheloop.mayoclinic.org. Accessed July 19, 2016.
  10. Singla A, et al. Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biology of Blood and Marrow Transplantation. 2013;19:1233.
  11. Hoffman R, et al. Overview of hematopoietic stem cell transplantation. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed July 19, 2016.
  12. Dispenzieri A. POEMS syndrome: 2012 update on diagnosis, risk-stratification and management. American Journal of Hematology. 2012;87:804.
  13. Yang ZZ, et al. T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: Activation, suppression and exhaustion. Leukemia and Lymphoma. 2015;56:2498.
  14. Diseases treatable by transplants. National Marrow Donor Program. https://bethematch.org/transplant-basics/how-transplants-work/diseases-treatable-by-transplants/. Accessed July 20, 2016.
  15. Majhail NS, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 2012;18:348.
  16. Yawn BP, et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312:1033.
  17. NCCN member institutions. National Comprehensive Cancer Network. https://www.nccn.org. Accessed July 20, 2016.
  18. Cordes S, et al. Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency. Blood Coagulation and Fibrinolysis. 2016;27:101.
  19. Colborn LK. Office of Access Management. Mayo Clinic, Rochester, Minn. Jan. 28, 2016.
  20. Gertz MA, et al. Autologous stem cell transplant in 716 patients with multiple myeloma: Low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clinic Proceedings. 2008;83:1131.
  21. O'Suoji C, et al. Rare pediatric non-Hodgkin lymphomas: A report from Children's Oncology Group Study ANHL 04B1. Pediatric Blood Cancer. 2016;63:794.
  22. Galardy PJ, et al. Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: Therapeutic horizons. British Journal of Haematology. 2016;173:625.
  23. Slack JL, et al. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: Outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch. Biology of Blood and Marrow Transplantation. 2013;19:1167.
  24. King AA, et al. Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. American Journal of Hematology. 2015;90:1093.
  25. Mayo Clinic to grow human cells in space: Testing stroke treatment. Mayo Clinic News Network. http://newsnetwork.mayoclinic.org. Accessed July 20, 2016.
  26. Muchtar E, et al. Autologous stem cell transplant for multiple myeloma patients 70 years or older. Bone Marrow Transplant. In press.
  27. Ansell SM. Targeting immune checkpoints in lymphoma. Current Opinion in Hematology. 2015;22:337.
  28. Hashmi S, et al. Survival aster mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: Systematic review and meta-analysis. The Lancet Haematology. 2016;1:e45-52. https://www.clinicalkey.com. Accessed July 20, 2016.